a derivative of atropine[1] but atrovent spray a derivative of atropine[1] but is a quaternary amine and atrovent spray does not cross the blood-brain atrovent spray which prevents central side effects (anticholinergic syndrome).Ipratropium is also combined with fenoterol (trade names Combivent and Duoneb) for the management of asthma.Side effects are as those for.

8-azoniabicyclo[3.2.1] oct-3-yl] 3-hydroxy-2-phenyl-propanoateIdentifiersCAS number 60205-81-4ATC code R01AX03 R03BB01PubChem 43232DrugBank APRD00537Chemical dataFormula C20H30NO3Mol. mass 389.457 g/molSMILES eMolecules & atrovent spray dataBioavailability ?Protein binding 0 to 9% in atrovent spray atrovent spray life 2 hoursExcretion ?Therapeutic considerationsPregnancy cat. B(US)Legal status POM(UK)Routes InhalationIpratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic drug administered by inhalation for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and atrovent spray secretion. It is a quaternary amine and therefore does not diffuse into the blood, which prevents systemic side effects. Ipratropium is atrovent spray combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the treatment atrovent spray obstructive lung diseases. atrovent spray acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction.

of atropine[1] but is a derivative of atropine[1] but is a quaternary amine and therefore does not cross atrovent spray blood-brain barrier.